Amtelco will be an exhibitor at the HIMSS Global Health Conference & Exhibition.
MCFARLAND, Wis., Feb. 27, 2025 /PRNewswire/ — Today, Amtelco announced they will attend the Healthcare Information and Management Systems Society (HIMSS) annual conference for the 27th consecutive year. HIMSS25 will be held on March 3-6, 2025, in Las Vegas, Nevada. Amtelco can be found at booth 1521.
Amtelco is excited to introduce its latest innovation called Ellie® at HIMSS25. Ellie supports operators when call centers experience overwhelming call volumes due to limited staffing or peak-hour traffic conditions. Ellie reduces caller wait times with automation and intelligent call processing. Key features of Ellie include the following:
“Ellie supports hospital contact centers by working with agents to serve callers better and reduce operator workload,” said Tom Curtin, CEO of Amtelco. “Ellie handles basic inquiries using a large language model (LLM) with natural language processing (NLP). NLP enables Ellie to speak and understand speech like a human for a more life-like feel. Together, Ellie and your agents create a call experience that offers unparalleled service to patients and staff while providing cost-savings and scalability to your hospital call center.”
Ellie is the nickname of Eleanor Curtin, one of Amtelco’s co-founders and matriarch of the Curtin family who still owns and operates Amtelco. The name Ellie was purposefully chosen to honor the legacy of “Mrs. C” and to stress the importance of this product to Amtelco and its customers.
About Amtelco
Amtelco has been a leading provider of innovative communication applications since 1976. Amtelco’s healthcare branch was established in 1997 to offer solutions designed specifically for the healthcare industry and released its own HIPAA-compliant secure messaging app in 2011.
Today, Amtelco also offers AI-powered and cloud-based solutions and has systems operating in the United States and more than 20 foreign countries. Its sales and customer care staff are located throughout the United States, Canada, New Zealand, and Australia. Learn more about Amtelco at amtelco.com.
Media Inquiries:
Matt Everly
Amtelco
608-838-4194
maeverly@amtelco.com
SOURCE Amtelco
ATLANTA, GA AND DOHA, QATAR / ACCESS Newswire / December 6, 2025 / Ameerex Corporation…
SEATTLE, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage…
– Data support initiation of a combination cohort in the ongoing Phase 1 clinical trial…
SPRING, Texas, Dec. 06, 2025 (GLOBE NEWSWIRE) -- Io Therapeutics, Inc., a privately held pharmaceutical…
Ficerafusp alfa 750mg QW in combination with pembrolizumab demonstrates consistent overall response rate and safety…
TUS+VEN+AZA triplet frontline therapy demonstrates high rates of efficacy and MRD-negative remissions in newly diagnosed…